Ji 2023 — Mazdutide in Chinese Adults With Overweight or Obesity

Nature Communications

Linong Ji, et al.

Summary

Mazdutide up to 6 mg led to robust and clinically meaningful body-weight reduction over 24 weeks in Chinese adults.

Study Details

Study Design

Phase 2 randomized controlled trial

Indication

Overweight or obesity

Intervention

Once-weekly mazdutide up to 6 mg vs placebo

Species

Human

Sample Size

248 subjects

Risk of Bias Assessment

Sponsor-funded; China-only population